![Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen | Request PDF Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen | Request PDF](https://i1.rgstatic.net/publication/336012518_Neurofilament_light_chain_in_serum_of_adolescent_and_adult_SMA_patients_under_treatment_with_nusinersen/links/5fb7df53458515b79759be67/largepreview.png)
Neurofilament light chain in serum of adolescent and adult SMA patients under treatment with nusinersen | Request PDF
Therapeutic decisions under uncertainty for spinal muscular atrophy: The DECISIONS-SMA study protocol | PLOS ONE
![Nutrients | Free Full-Text | Nutritional, Gastrointestinal and Endo-Metabolic Challenges in the Management of Children with Spinal Muscular Atrophy Type 1 Nutrients | Free Full-Text | Nutritional, Gastrointestinal and Endo-Metabolic Challenges in the Management of Children with Spinal Muscular Atrophy Type 1](https://www.mdpi.com/nutrients/nutrients-13-02400/article_deploy/html/images/nutrients-13-02400-g001.png)
Nutrients | Free Full-Text | Nutritional, Gastrointestinal and Endo-Metabolic Challenges in the Management of Children with Spinal Muscular Atrophy Type 1
![Spinal Muscular Atrophy as a Treatable Disease: Disease-Modifying Therapies Improving Clinical Outcomes and Quality of Life - Neurology Advisor Spinal Muscular Atrophy as a Treatable Disease: Disease-Modifying Therapies Improving Clinical Outcomes and Quality of Life - Neurology Advisor](https://www.neurologyadvisor.com/wp-content/uploads/sites/10/2022/04/CCH_HowToTreat_Neuro_SMA_Hero_neurongene_v2.png)